ABSTRACT
Cholesterol crystal (CC) embolism is a disease in which CCs from atherosclerotic lesions embolize peripheral arteries, causing organ dysfunction. In this case, a patient with spontaneously ruptured aortic plaques (SRAPs) identified by non-obstructive general angioscopy (NOGA) may have developed a CC embolism. This is the first report of a CC embolism in a patient with SRAPs identified using NOGA, which further supports the previously speculated pathogenesis of CC embolism due to SRAPs.
Subject(s)
Angioscopy , Embolism, Cholesterol , Plaque, Atherosclerotic , Humans , Embolism, Cholesterol/complications , Embolism, Cholesterol/diagnosis , Angioscopy/methods , Plaque, Atherosclerotic/complications , Plaque, Atherosclerotic/diagnosis , Plaque, Atherosclerotic/diagnostic imaging , Male , Aortic Rupture/complications , Aortic Rupture/diagnosis , Rupture, Spontaneous , AgedABSTRACT
Cholesterol embolization syndrome is an increasing but underestimated problem after endovascular intervention or after the start of thrombolytic therapies. Embolies from the aortic wall involves abdominal organs and the skin of the lower extremities or buttocks. In our case a progressive ulceration and necroses occurs spontaneously. Endovascular treatment of the lower extremities was successful for a short period. Due to the progression of necrosis, both legs were amputated. Biopsies were taken from the skin were initially no directions to the diagnosis of Cholesterol embolization syndrome. After a second elliptical excision biopsy the diagnosis of cholesterol embolization syndrome was confirmed. Because the rapid progression of skin necroses despite the treatment of prednisone, patient died due to sepsis and renal failure. This case shows when arterial revascularization is performed and progression in skin necrosis occurs despite optimal arterial vascular status the diagnosis CES should be considered and treated in an early state of disease.
Subject(s)
Embolism, Cholesterol , Humans , Embolism, Cholesterol/diagnosis , Embolism, Cholesterol/pathology , Embolism, Cholesterol/therapy , Skin/pathology , Arteries , NecrosisABSTRACT
BACKGROUND: Cholesterol crystal embolization syndrome (CES) occurs when an atherosclerotic plaque causes small-vessel embolization, resulting in multi-organ damage. Although CES is pathologically characterized by an infiltration of eosinophils, the implication of the systemic inflammatory response represented by hypereosinophilia is unclear in clinical practice. Herein we present the case of a patient diagnosed with CES who developed multiple allergic organ injuries, including daptomycin-related dermatitis and later vancomycin-induced acute tubulointerstitial nephritis, which was successfully treated by the withdrawal of each medicine with or without corticosteroid therapy, one by one. CASE PRESENTATION: A 76-year-old Japanese man diagnosed with thoracic aneurysm rupture underwent total arch replacement through the open stent graft technique. Postoperatively, he developed methicillin-resistant Staphylococcus epidermidis bacteremia, which was treated with daptomycin. Subsequently, he presented with palpable purpura on both dorsal feet, erythema around his body, and hypereosinophilia. Daptomycin was replaced with vancomycin due to suspicion of drug-induced erythema. The erythema gradually faded. On nine days after vancomycin therapy, the systemic erythema rapidly reappeared followed by acute renal failure. The renal function decline prompted hemodialysis. A skin biopsy revealed cholesterol embolization, whereas a kidney biopsy revealed acute tubulointerstitial nephritis. After vancomycin discontinuation and initiation of systemic corticosteroid treatment, his kidney function was restored to the baseline level. CONCLUSIONS: The present case highlights cholesterol embolization can cause allergic complications in addition to direct organ damage.
Subject(s)
Daptomycin , Embolism, Cholesterol , Methicillin-Resistant Staphylococcus aureus , Aged , Cholesterol , Embolism, Cholesterol/complications , Embolism, Cholesterol/diagnosis , Humans , Immunity , Male , Nephritis, Interstitial , Vancomycin/therapeutic useABSTRACT
Cholesterol crystal embolism (CCE) is a rare but serious complication of percutaneous coronary intervention (PCI). However, its incidence, risk factors, and prognosis in the contemporary era are not well known. We included 23,184 patients who underwent PCI in our institution between January 2000 and December 2019 in this study. The diagnosis of CCE was made histologically or by the combination of cutaneous signs and specific blood test results. In patients with CCE, we evaluated the incidence, risk factors, and prognosis. A total of 88 patients (0.38%) were diagnosed with CCE. The incidence of CCE seemed to decline through the investigated 20 years. Positive predictors of CCE were age ≥70 years (68% vs 59%, p = 0.012), aortic aneurysm (23% vs 7.2% p <0.001), and a femoral approach (71% vs 45%, p <0.001), whereas a negative predictor of CCE was the use of an inner sheath (63% vs 77%, p <0.001). The rate of 1-year mortality and the requirement for chronic hemodialysis within 1 year after PCI in patients with CCE were 10% and 11%, respectively. The use of an inner sheath and a nonfemoral approach was associated with a lower incidence of CCE. In conclusion, because the prognosis of patients with CCE is still poor, preprocedural identification of high-risk patients and selection of low-risk procedures could be important for preventing CCE.
Subject(s)
Embolism, Cholesterol , Percutaneous Coronary Intervention , Aged , Cholesterol , Embolism, Cholesterol/complications , Embolism, Cholesterol/diagnosis , Embolism, Cholesterol/epidemiology , Humans , Incidence , Percutaneous Coronary Intervention/adverse effects , Prognosis , Risk Factors , Treatment OutcomeABSTRACT
The increase in patients' average age, the enhancement of anticoagulation therapy and the growth of vascular interventions represent the perfect conditions for the onset of atheroembolic renal disease. AERD is observed in patients with diffuse atherosclerosis, generally after a triggering event such as surgery on the aorta, invasive procedures (angiography, catheterization of the left ventricle, coronary angioplasty) and anticoagulant or fibrinolytic therapy. The clinical signs are heterogeneous, a consequence of the occlusion of downstream small arterial vessels by cholesterol emboli coming from atheromatous plaques of the aorta, or one of its main branches. The proximity of the kidneys to the abdominal aorta, and the high flow of blood they receive, make them a major target organ. For this reason, AERD represents a pathological condition that always needs to be taken into account in the nephropathic patient, although its systemic nature makes the diagnosis difficult. This manuscript presents a review of the existing literature on this pathology, to provide an updated summary of the state of the art: risk factors, diagnostics, histology and therapeutic approaches.
Subject(s)
Atherosclerosis , Embolism, Cholesterol , Kidney Diseases , Atherosclerosis/complications , Embolism, Cholesterol/complications , Embolism, Cholesterol/diagnosis , Embolism, Cholesterol/therapy , Humans , Kidney , Kidney Diseases/etiology , Kidney Diseases/therapy , Risk FactorsABSTRACT
Cholesterol embolization syndrome is an uncommon complication of coronary angioplasty. Its clinical manifestations are nonspecific and may be ascribed to other causes mimicking vasculitis syndrome. In an appropriate clinical setting, the diagnosis can be confirmed by tissue biopsy. In this case report, we present a middle-aged male who presented with cutaneous and renal manifestations within two weeks of primary angioplasty. The patient had progressive clinical deterioration in the form of dry gangrene of toes and end-stage renal disease requiring surgical amputation and maintenance hemodialysis respectively within two months of symptoms onset.
Subject(s)
Embolism, Cholesterol , Kidney Failure, Chronic , Vasculitis , Embolism, Cholesterol/complications , Embolism, Cholesterol/diagnosis , Female , Humans , Kidney/pathology , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/therapy , Male , Middle Aged , Renal Dialysis/adverse effects , Vasculitis/etiologyABSTRACT
Cholesterol crystal embolization (CCE) shows a poor prognosis and it can cause ischemic organ damage due to a cholesterol embolism from atherosclerotic lesions in large blood vessels. Such an embolism mainly affects the kidneys and skin, although cases involving digestive organs have also been reported. We encountered an autopsy case of CCE with damage mainly to the digestive organs, including the pancreas. The patient had non-specific abdominal symptoms or image findings. Symptomatic therapy failed to save him. CCE can involve the digestive organs, and so must be differentiated from abdominal pathologies. Moreover, conventional treatments may be ineffective, and new treatments might thus be necessary.
Subject(s)
Embolism, Cholesterol , Pancreatitis , Acute Disease , Autopsy , Cholesterol , Embolism, Cholesterol/complications , Embolism, Cholesterol/diagnosis , Humans , Male , Pancreatitis/diagnosis , Pancreatitis/etiologyABSTRACT
Ischemia is a common complication of various endovascular procedures including endovascular aortic aneurysm repair. Multiple mechanisms can contribute to the pathogenesis of ischemia: thrombosis, arterial dissection, graft malpositioning, cholesterol embolization, and polymer graft embolization which is an underrecognized complication. To the best of our knowledge, only 38 cases of polymer graft embolization have been reported in the literature. The phenomenon has been reported in different organs including brain, heart, lungs, kidneys, bowel, liver, and skin. We report a unique case of fatal simultaneous cholesterol and polymer graft embolization with subsequent ischemic infarction of multiple organs (liver, kidneys, spleen, pancreas, duodenum, and stomach) in a 76-year-old woman following endovascular repair for an enlarging thoracic aortic aneurysm.
Subject(s)
Aortic Aneurysm, Thoracic/surgery , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Embolism, Cholesterol/etiology , Endovascular Procedures/instrumentation , Foreign-Body Migration/etiology , Infarction/etiology , Multiple Organ Failure/etiology , Aged , Aortic Aneurysm, Thoracic/diagnostic imaging , Autopsy , Blood Vessel Prosthesis Implantation/adverse effects , Embolism, Cholesterol/diagnosis , Endovascular Procedures/adverse effects , Fatal Outcome , Female , Foreign-Body Migration/diagnosis , Humans , Infarction/diagnosis , Multiple Organ Failure/diagnosis , Treatment OutcomeABSTRACT
While prompt diagnosis of vasculitis is important, recognition of vasculitis mimics is equally essential. As in the case of vasculitis, an approach to mimics based on the anatomic size of vessels can be useful. Infections can mimic vasculitis of any vessel size, including the formation of aneurysms and induction of ANCAs. Genetic disorders and vasculopathies are important considerations in large and medium vessel vasculitis. Cholesterol emboli, thrombotic conditions and calciphylaxis typically affect the medium and small vessels and, like vasculitis, can cause cutaneous, renal and CNS manifestations. Reversible cerebral vasoconstriction syndrome is important to distinguish from primary angiitis of the CNS. As an incorrect diagnosis of vasculitis can result in harmful consequences, it is imperative that the evaluation of suspected vasculitis includes consideration of mimics. We discuss the above mimics and outline a systematic and practical approach for differentiating vasculitis from its mimics.
Subject(s)
Vasculitis/diagnosis , Diagnosis, Differential , Embolism, Cholesterol/diagnosis , Endocarditis/diagnosis , Humans , Thrombophilia/diagnosisSubject(s)
Embolism, Cholesterol/diagnosis , Erythema/diagnosis , Gangrene/diagnosis , Livedo Reticularis/diagnosis , Peripheral Arterial Disease/diagnosis , Aged , Diagnosis, Differential , Embolism, Cholesterol/etiology , Erythema/etiology , Foot/pathology , Gangrene/etiology , Humans , Leg/pathology , Livedo Reticularis/complications , Male , Medical Illustration , Peripheral Arterial Disease/complications , SyndromeABSTRACT
⺠Foot pain ⺠"Purple" toe ⺠History of smoking.